The Food and Drug Administration has approved a new drug to treat low sexual drive in women, the only one besides Addyi, which entered the market in 2015.
The drug, to be called Vyleesi, will be sold by AMAG Pharmaceuticals and is intended to be used 45 …
Read more via NYT – Health –...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.